Celon Pharma SA's total assets for Q3 2025 were zł471.33M, a decrease of -2.34% from the previous quarter. PL:CLN total liabilities were zł82.14M for the fiscal quarter, a -15.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.